Connecting early-stage life science founders across Europe to share insights and experiences

Application to nextGEN @LifeScience ORG

Name

First Name

Last Name

LinkedIn Profile

http://

Are you the Founding CEO / Managing Director of the venture?

nextGEN is open to one lead founder per venture.

Yes

Have you incorporated?

nextGEN is open to founders of ventures at the pre-seed and seed stage.

Yes

Are you:

Biotech

Medtech

Healthtech

Other (Agritech, Techbio, etc.)

Name of your venture:

Location of your venture:

Please list any incubator or accelerator programs you have been a part of:

Have you raised any money and if so how much?

You agree to receive event invitations and updates.

We do not sell emails or send advertisements.

Yes

- Elevating the leadership journey of life science entrepreneurs

100+ of the world’s brightest life science founders, sharing insights on the important issues faced when building a life science venture

Leading European centres of excellence, such as Imperial College, VIB, BioInnovation Institute, ETH, Uni Zurich, Spark Europe, Max Planck Innovation, Ascenion and others partnered with us to launch nextGEN, bringing their founders into our community.

The nextGEN program is curated around monthly topics and different meeting formats:

INSIGHTS: world-class thought leaders and LifeScience ORG CEOs sharing their learnings.
ROUNDTABLE: informal peer-to-peer conversation on topics such as fundraising, pitching, etc.
OFFICE HOURS & WORKSHOPS: hosted by our partners.

“The nextGEN @LifeScience ORG founder community platform perfectly complements our own pre-seed start-up support in the life science sector, providing our biotech founders with sector specific information from senior industry experts and peer exchange opportunities relevant for a successful start and advancement of their start-up.”- Ulrich Mahr, Max-Planck-Innovation GmbH

Our Partners:

But don’t just take our word for it:

Get in touch

Upcoming Events

Featured

INSIGHTS/The Investor: Alex Brunicki & Yasmin Siraj (BackedVC) - Top 10 mistakes we have seen Founders make

May 8

May 8, 2024

INSIGHTS/The Investor: Alex Brunicki & Yasmin Siraj (BackedVC) - Top 10 mistakes we have seen Founders make

May 8, 2024

Alex Brunicki - Co-Founder and Partner at Backed

Yasmin Siraj - Investment Manager at Backed

Backed has helped 110+ entrepreneurs successfully scale 60+ companies across Europe and they have seen a lot of founders make mistakes along the way in their early journeys.

May 8, 2024

May 16

May 16, 2024

Roundtable: Fundraising

May 16, 2024

Monthly informal lunchtime session hosted by Nikolai Ahrens.

May 16, 2024

Jun 6

Jun 6, 2024

Roundtable: Fundraising

Jun 6, 2024

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Jun 6, 2024

INSIGHTS/The Expert: Randall Peterson (London Business School) - Personality Bear Traps

Jun 11

Jun 11, 2024 – Jun 12, 2024

INSIGHTS/The Expert: Randall Peterson (London Business School) - Personality Bear Traps

Jun 11, 2024 – Jun 12, 2024

Dr. Randall S. Peterson - Professor of Organisational Behaviour and Founding Director of the London Business School Leadership Institute at London Business School.

He is former Deputy Dean (Faculty) of the School, Vice President of the School’s fundraising campaign committee, Chair of the Organisational Behaviour Subject Area, and of the London Business School Ph.D. Programme. He teaches executive and MBA classes on leading teams and organisations, board dynamics, high performance teams, leadership assessment and skill development.

Jun 11, 2024 – Jun 12, 2024

Past Events

Featured

Apr 17

INSIGHTS/The Investor: Rabab Nasrallah (Earlybird Venture Capital) - Delivering the perfect pitch

Rabab Nasrallah - Earlybird Venture Capital

Rabab Nasrallah, PhD is a Healthcare Investment Professional at Earlybird Venture Capital, investing in early-stage companies across digital health, medical devices, diagnostics, R&D platform technologies, and biopharma. Currently, Rabab is a board member of Grey Wolf Therapeutics and a board observer of ImCheck Therapeutics, Atlantic Therapeutics, Argá Medtech, and Priothera.

Apr 4

MASTERMIND: Maximilien Levesque (AQEMIA) - Raising €60 mio of Series A financing

Maximilien Levesque - CEO at AQEMIA

MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

Apr 3

INSIGHTS/The Expert: Alex Gould (Founder and CEO Long Story Short) - Crafting your Pitch Deck(s)

Alex Gould - Founder and CEO of Long Story Short

A seasoned communications and design specialist, Alex is an expert at simplifying and transforming technical subject matter into compelling campaigns that excite and persuade audiences.

Mar 21

Roundtable: Fundraising

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Mar 13

INSIGHTS/The CEO: Mark Kotter (bit.bio Founder and CEO) - Building a network of Advocates for you and your Venture

Mark Kotter - Founder and CEO of bit.bio

Mark Kotter is a stem cell biologist and neurosurgeon at the University of Cambridge.

Mar 6

INSIGHTS/The Expert: Matt Abrahams (Stanford University Graduate School of Business): THINK FAST, TALK SMART - Communication Tools for Founders.

Matt Abrahams - Lecturer in Organizational Behavior at Stanford University’s Graduate School of Business

Matt is a leading expert in communication with decades of experience as an educator, author, podcast host, and coach.

Feb 21

INSIGHTS/The CEO: Anna Sumeray (CEO Virometix) - It takes a great team and brutal honesty about the data

Anna Sumeray - CEO at Virometix

Anna Sumeray has over 25 years of experience in the life sciences sector with a combination of strategic consultancy, hands-on P&L leadership and deal transaction experience in big pharmaceutical and small biotechnology companies, globally, across Europe and within individual countries.

Feb 15

Roundtable: Fundraising

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Feb 7

INSIGHTS/The Expert: Jack Scannell (CEO of Etheros) - Designing your pre-clinical Journey

Jack Scannell - CEO at Etheros

He is an Associate of the Department of Science, Technology, and Innovation Studies at Edinburgh University. He led Discovery Biology at e-Therapeutics PLC. He has experience in drug and biotech investment at UBS and at Sanford Bernstein where he ran the European Healthcare teams. He has a Ph.D. in neuroscience from Oxford University and a degree in medical sciences from Cambridge University.

Jan 31

INSIGHTS/The CEO: Danuta Jeziorska (CEO & Academic Founder Nucleome Therapeutics) - The first 15 hires.

Danuta Jeziorska - CEO & Academic Founder at Nucleome Therapeutics

Danuta has been the CEO of Nucleome since its inception has deep expertise in gene regulation, transcription, epigenetics, 3D genome analysis and bioinformatics. In acknowledgement of her achievements at Nucleome, Danuta was recently recognised as an outstanding leader in the biotech sector by leading scientific journal Nature Biotechnology.

Jan 25

Roundtable: Fundraising

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Jan 17

INSIGHTS/The Expert: Tariq Ahmed (EVP People, Achilles Therapeutics) - Setting up a Hiring Process

Tariq Ahmed - EVP People, Achilles Therapeutics

Tariq Ahmed serves as Executive Vice President, People at Achilles Therapeutics helping navigate their growth from a small private bio-tech to a NASDAQ listed company.